Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Thomas Unger

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Procedures

Intraventricular Injections

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
47
Gohlke, Peter
45
Culman, Juraj
26
Kintscher, Ulrich
19
Tschöpe, Carsten
18
Blume, Annegret
17
Steckelings, Ulrike Muscha
15
Lebrun, CJ
14
Sandmann, Steffen
14
Stauss, Harald
14
Kaschina, Elena
14
Ganten, Detlev
13
Chung, O
12
Herdegen, Thomas
12
Reinecke, Alexander
10
Stoll, Monika

Sign-in to see all Coauthors

Publications

TOP 3
Vosgerau Uwe; Lauer Diljara; Unger Thomas; Kaschina Elena
Cleaved high molecular weight kininogen, a novel factor in the regulation of matrix metalloproteinases in vascular smooth muscle cells.
Steckelings Ulrike Muscha; Rompe Franziska; Kaschina Elena; Unger Thomas
The evolving story of the RAAS in hypertension, diabetes and CV disease - moving from macrovascular to microvascular targets.
Kappert Kai; Tsuprykov Oleg; Kaufmann Jan; Fritzsche Jan; Ott Ingo; Goebel Matthias; Bähr Ilse Nirmala; Hässle Paul-Laszlo; Gust Ronald; Fleck Eckart; Unger Thomas; Stawowy Philipp; Kintscher Ulrich
Chronic treatment with losartan results in sufficient serum levels of the metabolite EXP3179 for PPARgamma activation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Thomas Unger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Vosgerau Uwe; Lauer Diljara; Unger Thomas; Kaschina Elena
Cleaved high molecular weight kininogen, a novel factor in the regulation of matrix metalloproteinases in vascular smooth muscle cells.
Biochemical pharmacology 2010;79(2):172-9.
2009: Steckelings Ulrike Muscha; Rompe Franziska; Kaschina Elena; Unger Thomas
The evolving story of the RAAS in hypertension, diabetes and CV disease - moving from macrovascular to microvascular targets.
Fundamental & clinical pharmacology 2009;23(6):693-703.
2009: Kappert Kai; Tsuprykov Oleg; Kaufmann Jan; Fritzsche Jan; Ott Ingo; Goebel Matthias; Bähr Ilse Nirmala; Hässle Paul-Laszlo; Gust Ronald; Fleck Eckart; Unger Thomas; Stawowy Philipp; Kintscher Ulrich
Chronic treatment with losartan results in sufficient serum levels of the metabolite EXP3179 for PPARgamma activation.
Hypertension 2009;54(4):738-43.
2009: Altarche-Xifró Wassim; Curato Caterina; Kaschina Elena; Grzesiak Aleksandra; Slavic Svetlana; Dong Jun; Kappert Kai; Steckelings Muscha; Imboden Hans; Unger Thomas; Li Jun
Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance.
Stem cells (Dayton, Ohio) 2009;27(10):2488-97.
2009: Kaschina Elena; Scholz Hans; Steckelings U Muscha; Sommerfeld Manuela; Kemnitz Ulrich Rudolf; Artuc Metin; Schmidt Sven; Unger Thomas
Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components.
Atherosclerosis 2009;205(2):396-403.
2009: Goebel Matthias; Staels Bart; Unger Thomas; Kintscher Ulrich; Gust Ronald
Characterization of new PPARgamma agonists: benzimidazole derivatives - the importance of position 2.
ChemMedChem 2009;4(7):1136-42.
2009: Brinckmann Marie; Kaschina Elena; Altarche-Xifró Wassim; Curato Caterina; Timm Melanie; Grzesiak Aleksandra; Dong Jun; Kappert Kai; Kintscher Ulrich; Unger Thomas; Li Jun
Estrogen receptor alpha supports cardiomyocytes indirectly through post-infarct cardiac c-kit+ cells.
Journal of molecular and cellular cardiology 2009;47(1):66-75.
2009: Steckelings U Muscha; Unger Thomas
Angiotensin receptors and autophagy: live and let die.
Hypertension 2009;53(6):898-9.
2009: Reinemund Jana; Seidel Kerstin; Steckelings Ulrike M; Zaade Daniela; Klare Sabrina; Rompe Franziska; Katerbaum Marlen; Schacherl Jens; Li Yaosi; Menk Mario; Schefe Jan H; Goldin-Lang Petra; Szabo Csaba; Olah Gabor; Unger Thomas; Funke-Kaiser Heiko
Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genes.
Biochemical pharmacology 2009;77(12):1795-805.
2009: Goebel Matthias; Clemenz Markus; Staels Bart; Unger Thomas; Kintscher Ulrich; Gust Ronald
Characterization of new PPARgamma agonists: analysis of telmisartan's structural components.
ChemMedChem 2009;4(3):445-56.
2008: Kaschina Elena; Grzesiak Aleksandra; Li Jun; Foryst-Ludwig Anna; Timm Melanie; Rompe Franziska; Sommerfeld Manuela; Kemnitz U Rudolf; Curato Caterina; Namsolleck Pawel; Tschöpe Carsten; Hallberg Anders; Alterman Mathias; Hucko Thomas; Paetsch Ingo; Dietrich Thore; Schnackenburg Bernhard; Graf Kristof; Dahlöf Björn; Kintscher Ulrich; Unger Thomas; Steckelings U Muscha
Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?
Circulation 2008;118(24):2523-32.
2008: Thöne-Reineke Christa; Neumann Christian; Namsolleck Pawel; Schmerbach Kristin; Krikov Maxim; Schefe Jan H; Lucht Kristin; Hörtnagl Heide; Godes Michael; Müller Susanne; Rumschüssel Kay; Funke-Kaiser Heiko; Villringer Arno; Steckelings U Muscha; Unger Thomas
The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke.
Journal of hypertension 2008;26(12):2426-35.
2008: Kaschina Elena; Schrader Felix; Sommerfeld Manuela; Kemnitz Ulrich Rudolf; Grzesiak Aleksandra; Krikov Maxim; Unger Thomas
Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation.
Journal of hypertension 2008;26(12):2361-73.
2008: Kintscher Ulrich; Foryst-Ludwig Anna; Unger Thomas
Inhibiting angiotensin type 1 receptors as a target for diabetes.
Expert opinion on therapeutic targets 2008;12(10):1257-63.
2008: Schefe Jan H; Neumann Christian; Goebel Matthias; Danser Jan; Kirsch Sebastian; Gust Ronald; Kintscher Ulrich; Unger Thomas; Funke-Kaiser Heiko
Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren.
Journal of hypertension 2008;26(9):1787-94.
2008: Kintscher Ulrich; Hartge Martin; Hess Katharina; Foryst-Ludwig Anna; Clemenz Markus; Wabitsch Martin; Fischer-Posovszky Pamela; Barth Thomas F E; Dragun Duska; Skurk Thomas; Hauner Hans; Blüher Matthias; Unger Thomas; Wolf Anna-Maria; Knippschild Uwe; Hombach Vinzenz; Marx Nikolaus
T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(7):1304-10.
2008: Unger Thomas
["Hypertension 2008"]
MMW Fortschritte der Medizin 2008;150(24):26.
2008: Foryst-Ludwig Anna; Clemenz Markus; Hohmann Stephan; Hartge Martin; Sprang Christiane; Frost Nikolaj; Krikov Maxim; Bhanot Sanjay; Barros Rodrigo; Morani Andrea; Gustafsson Jan-Ake; Unger Thomas; Kintscher Ulrich
Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma.
PLoS genetics 2008;4(6):e1000108.
2008: Kappert K; Unger T; Kintscher U
[Aliskiren hemifumarate]
Deutsche medizinische Wochenschrift (1946) 2008;133(24):1308-12.
2008: Schefe Jan H; Unger Thomas; Funke-Kaiser Heiko
PLZF and the (pro)renin receptor.
Journal of molecular medicine (Berlin, Germany) 2008;86(6):623-7.
2008: Schmerbach Kristin; Schefe Jan H; Krikov Maxim; Müller Susanne; Villringer Arno; Kintscher Ulrich; Unger Thomas; Thoene-Reineke Christa
Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain.
Brain research 2008;1208():225-33.
2008: Clemenz Markus; Frost Nikolaj; Schupp Michael; Caron Sandrine; Foryst-Ludwig Anna; Böhm Christian; Hartge Martin; Gust Ronald; Staels Bart; Unger Thomas; Kintscher Ulrich
Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan.
Diabetes 2008;57(5):1405-13.
2008: Krikov Maxim; Thone-Reineke Christa; Müller Susanne; Villringer Arno; Unger Thomas
Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats.
Journal of hypertension 2008;26(3):544-52.
2008: Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann S-M; Young M F; Schultheiss H P; Levkau B; Baba H A; Unger T; Zacharowski K; Tschöpe C; Fischer J W
Biglycan is required for adaptive remodeling after myocardial infarction.
Circulation 2008;117(10):1269-76.
2008: Kappert Kai; Kusserow Heike; Unger Thomas
The pharmacological rationale behind polypharmacy in heart failure.
Heart failure monitor 2008;6(1):20-7.
2008: Unger Thomas; Jakobsen Anne; Heroys Jose; Ralph Ann; Rees Tomas; Shaw Michael
Targeting cardiovascular protection: the concept of dual renin-angiotensin system control.
Medscape journal of medicine 2008;10 Suppl():S4.
2007: Li Jun; Doerffel Yvonne; Hocher Berthold; Unger Thomas
Inflammation in the genesis of hypertension and its complications--the role of angiotensin II.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(11):3107-9.
2007: Hoheisel Ulrich; Unger Thomas; Mense Siegfried
Sensitization of rat dorsal horn neurons by NGF-induced subthreshold potentials and low-frequency activation. A study employing intracellular recordings in vivo.
Brain research 2007;1169():34-43.
2007: Unger Thomas; Stoppelhaar Martina
Rationale for double renin-angiotensin-aldosterone system blockade.
The American journal of cardiology 2007;100(3A):25J-31J.
2007: Hartge Martin M; Unger Thomas; Kintscher Ulrich
The endothelium and vascular inflammation in diabetes.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2007;4(2):84-8.
2007: Scholze Jürgen; Grimm Elmar; Herrmann Dana; Unger Thomas; Kintscher Ulrich
Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.
Circulation 2007;115(15):1991-8.
2007: Steckelings Ulrike Muscha; Rettig Rainer; Unger Thomas
Angiotensin in the kidney: a key to understanding hypertension?
Cell metabolism 2007;5(1):7-8.
2007: Kintscher Ulrich; Bramlage Peter; Paar W Dieter; Thoenes Martin; Unger Thomas
Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
Cardiovascular diabetology 2007;6():12.
2006: Schefe Jan H; Menk Mario; Reinemund Jana; Effertz Karin; Hobbs Robin M; Pandolfi Pier Paolo; Ruiz Patricia; Unger Thomas; Funke-Kaiser Heiko
A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein.
Circulation research 2006;99(12):1355-66.
2006: Xia Qin-gui; Reinecke Alexander; Dorenkamp Marc; Daemen Mat Jap; Simon Reichiger; Unger Thomas
Effects of endothelin ETA receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure.
Acta pharmacologica Sinica 2006;27(11):1417-22.
2006: Schefe Jan H; Lehmann Kerstin E; Buschmann Ivo R; Unger Thomas; Funke-Kaiser Heiko
Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula.
Journal of molecular medicine (Berlin, Germany) 2006;84(11):901-10.
2006: Thone-Reineke C; Kalk P; Dorn M; Klaus S; Simon K; Pfab T; Godes M; Persson P; Unger T; Hocher B
High-protein nutrition during pregnancy and lactation programs blood pressure, food efficiency, and body weight of the offspring in a sex-dependent manner.
American journal of physiology. Regulatory, integrative and comparative physiology 2006;291(4):R1025-30.
2006: Goebel Matthias; Clemenz Markus; Unger Thomas
Effective treatment of hypertension by AT(1) receptor antagonism: the past and future of telmisartan.
Expert review of cardiovascular therapy 2006;4(5):615-29.
2006: Hartge Martin M; Kintscher Ulrich; Unger Thomas
Endothelial dysfunction and its role in diabetic vascular disease.
Endocrinology and metabolism clinics of North America 2006;35(3):551-60, viii-ix.
2006: Schupp Michael; Kintscher Ulrich; Fielitz Jens; Thomas Jennifer; Pregla Reinhard; Hetzer Roland; Unger Thomas; Regitz-Zagrosek Vera
Cardiac PPARalpha expression in patients with dilated cardiomyopathy.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2006;8(3):290-4.
2006: Unger Thomas
[Innovation or pseudo-innovation: that is the question]
Medizinische Klinik (Munich, Germany : 1983) 2006;101(3):257-62.
2006: Thöne-Reineke Christa; Steckelings Ulrike M; Unger Thomas
Angiotensin receptor blockers and cerebral protection in stroke.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2006;24(1):S115-21.
2006: Schupp Michael; Lee Lucas D; Frost Nikolaj; Umbreen Sumaira; Schmidt Boris; Unger Thomas; Kintscher Ulrich
Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites.
Hypertension 2006;47(3):586-9.
2006: Clemenz Markus; Kintscher Ulrich; Unger Thomas
The metabolic syndrome: cluster with a self-fulfilling loop?
Journal of hypertension 2006;24(2):257-8.
2006: Sandmann Steffen; Li Jun; Fritzenkötter Carolin; Spormann Johannes; Tiede Karen; Fischer Jens W; Unger Thomas
Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
Blood pressure 2006;15(2):116-28.
2005: Schupp Michael; Clemenz Markus; Gineste Romain; Witt Henning; Janke Jürgen; Helleboid Stephane; Hennuyer Nathalie; Ruiz Patricia; Unger Thomas; Staels Bart; Kintscher Ulrich
Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity.
Diabetes 2005;54(12):3442-52.
2005: Xu Jihong; Scholz Annedore; Rösch Nicole; Blume Annegret; Unger Thomas; Kreutz Reinhold; Culman Juraj; Gohlke Peter
Low-dose lithium combined with captopril prevents stroke and improves survival in salt-loaded, stroke-prone spontaneously hypertensive rats.
Journal of hypertension 2005;23(12):2277-85.
2005: Steckelings U M; Henz B M; Wiehstutz S; Unger T; Artuc M
Differential expression of angiotensin receptors in human cutaneous wound healing.
The British journal of dermatology 2005;153(5):887-93.
2005: Unger Thomas
[Laudatio. On the presentation of the 2005 Robert Koch Award to the drug tiotropium bromide (spiriva)]
Medizinische Klinik (Munich, Germany : 1983) 2005;100 Suppl 1():17-8.
2005: Hoheisel Ulrich; Unger Thomas; Mense Siegfried
The possible role of the NO-cGMP pathway in nociception: different spinal and supraspinal action of enzyme blockers on rat dorsal horn neurones.
Pain 2005;117(3):358-67.
2005: Zhao Yi; Foryst-Ludwig Anna; Bruemmer Dennis; Culman Juraj; Bader Michael; Unger Thomas; Kintscher Ulrich
Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation.
Journal of neurochemistry 2005;94(5):1395-401.
2005: Blume Annegret; Undeutsch Christian; Zhao Yi; Kaschina Elena; Culman Juraj; Unger Thomas
ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain.
American journal of physiology. Regulatory, integrative and comparative physiology 2005;289(3):R845-50.
2005: Clasen Ronald; Schupp Michael; Foryst-Ludwig Anna; Sprang Christiane; Clemenz Markus; Krikov Maxim; Thöne-Reineke Christa; Unger Thomas; Kintscher Ulrich
PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
Hypertension 2005;46(1):137-43.
2005: Kintscher U; Unger T
Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers.
Acta diabetologica 2005;42 Suppl 1():S26-32.
2005: Li Jun; Culman Juraj; Hörtnagl Heide; Zhao Yi; Gerova Nadezhda; Timm Melanie; Blume Annegret; Zimmermann Mathias; Seidel Kerstin; Dirnagl Ulrich; Unger Thomas
Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(6):617-9.
2005: Hoheisel Ulrich; Unger Thomas; Mense Siegfried
Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the rat.
Pain 2005;114(1-2):168-76.
2005: Dragun Duska; Müller Dominik N; Bräsen Jan Hinrich; Fritsche Lutz; Nieminen-Kelhä Melina; Dechend Ralf; Kintscher Ulrich; Rudolph Birgit; Hoebeke Johan; Eckert Diana; Mazak Istvan; Plehm Ralph; Schönemann Constanze; Unger Thomas; Budde Klemens; Neumayer Hans-Hellmut; Luft Friedrich C; Wallukat Gerd
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.
The New England journal of medicine 2005;352(6):558-69.
2005: Wruck Christoph J; Funke-Kaiser Heiko; Pufe Thomas; Kusserow Heike; Menk Mario; Schefe Jan H; Kruse Marie L; Stoll Monika; Unger Thomas
Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(1):57-64.
2005: Wilms Henrik; Rosenstiel Philip; Unger Thomas; Deuschl Günther; Lucius Ralph
Neuroprotection with angiotensin receptor antagonists: a review of the evidence and potential mechanisms.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2005;5(4):245-53.
2004: Unger Thomas; Li Jun
The role of the renin-angiotensin-aldosterone system in heart failure.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5 Suppl 1():S7-10.
2004: Kaschina Elena; Stoll Monika; Sommerfeld Manuela; Steckelings U Muscha; Kreutz Reinhold; Unger Thomas
Genetic kininogen deficiency contributes to aortic aneurysm formation but not to atherosclerosis.
Physiological genomics 2004;19(1):41-9.
2004: Thöne-Reineke Christa; Zimmermann Mathias; Neumann Christian; Krikov Maxim; Li Jun; Gerova Nadja; Unger Thomas
Are angiotensin receptor blockers neuroprotective?
Current hypertension reports 2004;6(4):257-66.
2004: Hoheisel Ulrich; Reinöhl Jochen; Unger Thomas; Mense Siegfried
Acidic pH and capsaicin activate mechanosensitive group IV muscle receptors in the rat.
Pain 2004;110(1-2):149-57.
2004: Tian Xiao-Li; Pinto Yigal Martin; Costerousse Olivier; Franz Wolfgang M; Lippoldt Andrea; Hoffmann Sigrid; Unger Thomas; Paul Martin
Over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats.
Human molecular genetics 2004;13(14):1441-50.
2004: Xia Qin-Gui; Reinecke Alexander; Dorenkamp Marc; Storz Christain; Bitterling Havvo; Penz Susanne; Cleutjens Jack; Daemen Mat Jap; Simon Reichiger; Unger Thomas
Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
Acta pharmacologica Sinica 2004;25(6):763-8.
2004: Zimmermann Mathias; Unger Thomas
Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programme.
Expert opinion on pharmacotherapy 2004;5(5):1201-8.
2004: Schupp Michael; Janke Jürgen; Clasen Ronald; Unger Thomas; Kintscher Ulrich
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity.
Circulation 2004;109(17):2054-7.
2004: Sharma Arya M; Wittchen Hans-Ulrich; Kirch Wilhelm; Pittrow David; Ritz Eberhard; Göke Burkhard; Lehnert Hendrik; Tschöpe Diethelm; Krause Petra; Höfler Michael; Pfister Hildegard; Bramlage Peter; Unger Thomas;
High prevalence and poor control of hypertension in primary care: cross-sectional study.
Journal of hypertension 2004;22(3):479-86.
2004: Kusserow Heike; Unger Thomas
Vasoactive peptides, their receptors and drug development.
Basic & clinical pharmacology & toxicology 2004;94(1):5-12.
2004: Unger Thomas; McInnes Gordon T; Neutel Joel M; Böhm Michael
The role of olmesartan medoxomil in the management of hypertension.
Drugs 2004;64(24):2731-9.
2004: Steckelings U Muscha; Stoppelhaar Martina; Sharma Arya M; Wittchen Hans-Ulrich; Krause Petra; Küpper Beate; Kirch Wilhelm; Pittrow David; Ritz Eberhard; Göke Burkhard; Lehnert Hendrik; Tschöpe Diethelm; Höfler Michael; Pfister Hildegard; Unger Thomas;
HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patients.
Blood pressure 2004;13(2):80-8.
2003: Tiede Karen; Stöter Katrin; Petrik Christian; Chen Wen Bin; Ungefroren Hendrik; Kruse Marie Luise; Stoll Monika; Unger Thomas; Fischer Jens W
Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGFbeta in vitro.
Cardiovascular research 2003;60(3):538-46.
2003: Groth Wolf; Blume Annegret; Gohlke Peter; Unger Thomas; Culman Juraj
Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats.
Journal of hypertension 2003;21(11):2175-82.
2003: Reinecke Kirstin; Lucius Ralph; Reinecke Alexander; Rickert Uta; Herdegen Thomas; Unger Thomas
Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(14):2094-6.
2003: Unger Thomas
Blood pressure lowering and renin-angiotensin system blockade.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2003;21(6):S3-7.
2003: Kintscher Ulrich; Bruemmer Dennis; Blaschke Florian; Unger Thomas; Law Ronald E
p38 MAP kinase negatively regulates angiotensin II-mediated effects on cell cycle molecules in human coronary smooth muscle cells.
Biochemical and biophysical research communications 2003;305(3):552-6.
2003: Hoheisel Ulrich; Scheifer Caroline; Trudrung Peter; Unger Thomas; Mense Siegfried
Pathophysiological activity in rat dorsal horn neurones in segments rostral to a chronic spinal cord injury.
Brain research 2003;974(1-2):134-45.
2003: Pees Christiane; Unger Thomas; Gohlke Peter
Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats.
The international journal of biochemistry & cell biology 2003;35(6):963-72.
2003: Unger Thomas
The ongoing telmisartan alone and in combination with ramipril global endpoint trial program.
The American journal of cardiology 2003;91(10A):28G-34G.
2003: Zhao Yi; Biermann Torsten; Luther Claudia; Unger Thomas; Culman Juraj; Gohlke Peter
Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells.
Journal of neurochemistry 2003;85(3):759-67.
2003: Tschöpe Carsten; Seidl Ulrich; Reinecke Alexander; Riester Udo; Graf Kristof; Schultheiss Heinz Peter; Hilgenfeldt Ulrich; Unger Thomas
Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
International immunopharmacology 2003;3(3):335-44.
2003: Reinöhl Jochen; Hoheisel Ulrich; Unger Thomas; Mense Siegfried
Adenosine triphosphate as a stimulant for nociceptive and non-nociceptive muscle group IV receptors in the rat.
Neuroscience letters 2003;338(1):25-8.
2003: Sandmann Steffen; Kaschina Elena; Blume Annegret; Kruse Marie Luise; Unger Thomas
Bradykinin B1 and B2 receptors differentially regulate cardiac Na+-H+ exchanger, Na+-Ca2+ exchanger and Na+-HCO3- symporter.
European journal of pharmacology 2003;458(1-2):3-16.
2003: Unger Thomas; Kaschina Elena
Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensives.
Drug safety : an international journal of medical toxicology and drug experience 2003;26(10):707-20.
2003: Kaschina Elena; Unger Thomas
Angiotensin AT1/AT2 receptors: regulation, signalling and function.
Blood pressure 2003;12(2):70-88.
2002: Sandmann Steffen; Spormann Johannes; Prenzel Freerk; Shaw Lee; Unger Thomas
Calcium channel blockade limits transcriptional, translational and functional up-regulation of the cardiac calpain system after myocardial infarction.
European journal of pharmacology 2002;453(1):99-109.
2002: Culman J; Blume A; Gohlke P; Unger T
The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers.
Journal of human hypertension 2002;16 Suppl 3():S64-70.
2002: Gohlke P; Kox T; Jürgensen T; von Kügelgen S; Rascher W; Unger T; Culman J
Peripherally applied candesartan inhibits central responses to angiotensin II in conscious rats.
Naunyn-Schmiedeberg's archives of pharmacology 2002;365(6):477-83.
2002: Gohlke Peter; Von Kügelgen Sebastian; Jürgensen Thomas; Kox Thomas; Rascher Wolfgang; Culman Juraj; Unger Thomas
Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats.
Journal of hypertension 2002;20(5):909-18.
2002: Sandmann Steffen; Prenzel Freerk; Shaw Lee; Schauer Roland; Unger Thomas
Activity profile of calpains I and II in chronically infarcted rat myocardium--influence of the calpain inhibitor CAL 9961.
British journal of pharmacology 2002;135(8):1951-8.
2002: Scheifer Caroline; Hoheisel Ulrich; Trudrung Peter; Unger Thomas; Mense Siegfried
Rats with chronic spinal cord transection as a possible model for the at-level pain of paraplegic patients.
Neuroscience letters 2002;323(2):117-20.
2002: Blume A; Neumann C; Dorenkamp M; Culman J; Unger T
Involvement of adrenoceptors in the angiotensin II-induced expression of inducible transcription factors in the rat forebrain and hypothalamus.
Neuropharmacology 2002;42(2):281-8.
2002: Unger Thomas
The role of the renin-angiotensin system in the development of cardiovascular disease.
The American journal of cardiology 2002;89(2A):3A-9A; discussion 10A.
2002: Sandmann Steffen; Unger Thomas
[Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure]
Drugs 2002;62 Spec No 1():43-52.
2002: Rosenstiel Philip; Gallinat Stefan; Arlt Alexander; Unger Thomas; Sievers Jobst; Lucius Ralph
Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?
CNS drugs 2002;16(3):145-53.
2001: Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
C-FOS expression in the rat brain in response to substance P and neurokinin B.
Brain research 2001;916(1-2):11-21.
2001: Unger T
Pharmacological properties of angiotensin II antagonists: examining all the therapeutic implications.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2001;2 Suppl 2():S4-7.
2001: Fischer J W; Stoll M; Hahn A W; Unger T
Differential regulation of thrombospondin-1 and fibronectin by angiotensin II receptor subtypes in cultured endothelial cells.
Cardiovascular research 2001;51(4):784-91.
2001: Gohlke P; Weiss S; Jansen A; Wienen W; Stangier J; Rascher W; Culman J; Unger T
AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats.
The Journal of pharmacology and experimental therapeutics 2001;298(1):62-70.
2001: Culman J; Baulmann J; Blume A; Unger T
The renin-angiotensin system in the brain: an update.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2001;2(2):96-102.
2001: Sandmann S; Yu M; Kaschina E; Blume A; Bouzinova E; Aalkjaer C; Unger T
Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+-H+ exchanger and Na+-HCO3- symporter in the rat heart after myocardial infarction.
Journal of the American College of Cardiology 2001;37(8):2154-65.
2001: Stoll M; Unger T
Angiotensin and its AT2 receptor: new insights into an old system.
Regulatory peptides 2001;99(2-3):175-82.
2001: Moellenhoff E; Blume A; Culman J; Chatterjee B; Herdegen T; Lebrun C J; Unger T
Effect of repetitive icv injections of ANG II on c-Fos and AT(1)-receptor expression in the rat brain.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;280(4):R1095-104.
2001: Blume A; Kaschina E; Unger T
Angiotensin II type 2 receptors: signalling and pathophysiological role.
Current opinion in nephrology and hypertension 2001;10(2):239-46.
2001: Sandmann S; Yu M; Unger T
Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor.
British journal of pharmacology 2001;132(3):767-77.
2001: Sandmann S; Claas R; Cleutjens J P; Daemen M J; Unger T
Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats.
Journal of cardiovascular pharmacology 2001;37(1):64-77.
2001: Xia Q G; Chung O; Spitznagel H; Illner S; Jänichen G; Rossius B; Gohlke P; Unger T
Significance of timing of angiotensin AT1 receptor blockade in rats with myocardial infarction-induced heart failure.
Cardiovascular research 2001;49(1):110-7.
2001: Unger T
Inhibiting renin-angiotensin in the brain: the possible therapeutic implications.
Blood pressure. Supplement 2001;1():12-6.
2000: Unger T; Azizi M; Belz G G
Blocking the tissue renin-angiotensin system: the future cornerstone of therapy.
Journal of human hypertension 2000;14 Suppl 2():S23-31.
2000: Zhu Y Z; Zhu Y C; Li J; Schäfer H; Schmidt W; Yao T; Unger T
Effects of losartan on haemodynamic parameters and angiotensin receptor mRNA levels in rat heart after myocardial infarction.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2000;1(3):257-62.
2000: Busche S; Gallinat S; Bohle R M; Reinecke A; Seebeck J; Franke F; Fink L; Zhu M; Sumners C; Unger T
Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study.
The American journal of pathology 2000;157(2):605-11.
2000: Stroth U; Blume A; Mielke K; Unger T
Angiotensin AT(2) receptor stimulates ERK1 and ERK2 in quiescent but inhibits ERK in NGF-stimulated PC12W cells.
Brain research. Molecular brain research 2000;78(1-2):175-80.
2000: Spitznagel H; Chung O; Xia Q; Rossius B; Illner S; Jähnichen G; Sandmann S; Reinecke A; Daemen M J; Unger T
Cardioprotective effects of the Na(+)/H(+)-exchange inhibitor cariporide in infarct-induced heart failure.
Cardiovascular research 2000;46(1):102-10.
2000: Sandmann S; Bohle R M; Dreyer T; Unger T
The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats.
Virchows Archiv : an international journal of pathology 2000;436(2):147-57.
2000: Chung O; Hinder M; Sharma A M; Bönner G; Middeke M; Platon J; Unger T
Comparison of the efficacy and safety of losartan (50-100 mg) with the T-type calcium channel blocker mibefradil (50-100 mg) in mild to moderate hypertension.
Fundamental & clinical pharmacology 2000;14(1):31-41.
2000: Unger T
Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetil.
Blood pressure. Supplement 2000;1():14-8.
2000: Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J
Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
Neuroscience 2000;95(3):813-20.
1999: Lucius R; Gallinat S; Busche S; Rosenstiel P; Unger T
Beyond blood pressure: new roles for angiotensin II.
Cellular and molecular life sciences : CMLS 1999;56(11-12):1008-19.
1999: Unger T
The angiotensin type 2 receptor: variations on an enigmatic theme.
Journal of hypertension 1999;17(12 Pt 2):1775-86.
1999: Chung O; Unger T
Angiotensin II receptor blockade and end-organ protection.
American journal of hypertension 1999;12(12 Pt 1-2):150S-156S.
1999: Xia Q G; Chung O; Spitznagel H; Sandmann S; Illner S; Rossius B; Jähnichen G; Reinecke A; Gohlke P; Unger T
Effects of a novel angiotensin AT(1) receptor antagonist, HR720, on rats with myocardial infarction.
European journal of pharmacology 1999;385(2-3):171-9.
1999: Tschöpe C; Reinecke A; Seidl U; Yu M; Gavriluk V; Riester U; Gohlke P; Graf K; Bader M; Hilgenfeldt U; Pesquero J B; Ritz E; Unger T
Functional, biochemical, and molecular investigations of renal kallikrein-kinin system in diabetic rats.
The American journal of physiology 1999;277(6 Pt 2):H2333-40.
1999: Min J Y; Sandmann S; Meissner A; Unger T; Simon R
Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
The Journal of pharmacology and experimental therapeutics 1999;291(3):1038-44.
1999: Unger T
Significance of angiotensin type 1 receptor blockade: why are angiotensin II receptor blockers different?
The American journal of cardiology 1999;84(10A):9S-15S.
1999: Dai W J; Funk A; Herdegen T; Unger T; Culman J
Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats.
Stroke; a journal of cerebral circulation 1999;30(11):2391-8; discussion 2398-9.
1999: Sandmann S; Min J Y; Meissner A; Unger T
Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats.
Cardiovascular research 1999;44(1):67-80.
1999: Tschöpe C; Koch M; Spillmann F; Heringer-Walther S; Mochmann H C; Stauss H; Bader M; Unger T; Schultheiss H P; Walther T
Upregulation of the cardiac bradykinin B2 receptors after myocardial infarction.
Immunopharmacology 1999;44(1-2):111-7.
1999: Tschöpe C; Walther T; Yu M; Reinecke A; Koch M; Seligmann C; Heringer S B; Pesquero J B; Bader M; Schultheiss H; Unger T
Myocardial expression of rat bradykinin receptors and two tissue kallikrein genes in experimental diabetes.
Immunopharmacology 1999;44(1-2):35-42.
1999: Zhu Y C; Zhu Y Z; Li J; Schäfer H; Schmidt W E; Unger T; Yao T
Effects of ramipril on cardiac gene transcription levels of angiotensin II receptors after myocardial infarction.
Zhongguo yao li xue bao = Acta pharmacologica Sinica 1999;20(6):481-5.
1999: Blume A; Herdegen T; Unger T
Angiotensin peptides and inducible transcription factors.
Journal of molecular medicine (Berlin, Germany) 1999;77(3):339-57.
1999: Gohlke P; Jürgensen T; von Kügelgen S; Unger T
Candesartan cilexetil: development and preclinical studies.
Drugs of today (Barcelona, Spain : 1998) 1999;35(2):105-15.
1999: Zhu Y C; Falkenhahn M; Franke F; Bohle R M; Stauss H M; Danilov S; Unger T
Expression of cardiac angiotensin-converting enzyme after myocardial infarction.
Zhongguo yao li xue bao = Acta pharmacologica Sinica 1999;20(2):97-102.
1999: Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T
Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
European journal of pharmacology 1999;367(2-3):255-65.
1999: Chung O; Csikós T; Unger T
Angiotensin II receptor pharmacology and AT1-receptor blockers.
Journal of human hypertension 1999;13 Suppl 1():S11-20; discussion S33-4.
1999: Gallinat S; Busche S; Schütze S; Krönke M; Unger T
AT2 receptor stimulation induces generation of ceramides in PC12W cells.
FEBS letters 1999;443(1):75-9.
1999: Stroth U; Unger T
The renin-angiotensin system and its receptors.
Journal of cardiovascular pharmacology 1999;33 Suppl 1():S21-8; discussion S41-3.
1998: Unger T; Culman J; Gohlke P
Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1998;16(7):S3-9.
1998: Chung O; Kühl H; Stoll M; Unger T
Physiological and pharmacological implications of AT1 versus AT2 receptors.
Kidney international. Supplement 1998;67():S95-9.
1998: Fischer J W; Tschöpe C; Reinecke A; Giachelli C M; Unger T
Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin.
Diabetes 1998;47(9):1512-8.
1998: Sandmann S; Spitznagel H; Chung O; Xia Q G; Illner S; Jänichen G; Rossius B; Daemen M J; Unger T
Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats.
Cardiovascular research 1998;39(2):339-50.
1998: Lucius R; Gallinat S; Rosenstiel P; Herdegen T; Sievers J; Unger T
The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats.
The Journal of experimental medicine 1998;188(4):661-70.
1998: Moellenhoff E; Lebrun C J; Blume A; Culman J; Herdegen T; Unger T
Central angiotensin AT1 and muscarinic receptors in ITF expression on intracerebroventricular NaCl.
The American journal of physiology 1998;275(1 Pt 2):R234-44.
1998: Gallinat S; Yu M; Dorst A; Unger T; Herdegen T
Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves.
Brain research. Molecular brain research 1998;57(1):111-22.
1998: Qadri F; Waldmann T; Wolf A; Höhle S; Rascher W; Unger T
Differential contribution of angiotensinergic and cholinergic receptors in the hypothalamic paraventricular nucleus to osmotically induced AVP release.
The Journal of pharmacology and experimental therapeutics 1998;285(3):1012-8.
1998: Csikós T; Chung O; Unger T
Receptors and their classification: focus on angiotensin II and the AT2 receptor.
Journal of human hypertension 1998;12(5):311-8.
1998: Qadri F; Wolf A; Waldmann T; Rascher W; Unger T
Sensitivity of hypothalamic paraventricular nucleus to C- and N-terminal angiotensin fragments: vasopressin release and drinking.
Journal of neuroendocrinology 1998;10(4):275-81.
1998: Steckelings U M; Bottari S P; Stoll M; Wagner J; Unger T
Repression of c-fos and c-jun gene expression is not part of AT2 receptor coupled signal transduction.
Journal of molecular medicine (Berlin, Germany) 1998;76(3-4):202-7.
1998: Csikós T; Balmforth A J; Grojec M; Gohlke P; Culman J; Unger T
Angiotensin AT2 receptor degradation is prevented by ligand occupation.
Biochemical and biophysical research communications 1998;243(1):142-7.
1998: Blume A; Seifert K; Lebrun C J; Möllenhoff E; Gass P; Unger T; Herdegen T
Differential time course of angiotensin-induced AP-1 and Krox proteins in the rat lamina terminalis and hypothalamus.
Neuroscience letters 1998;241(2-3):87-90.
1998: Stroth U; Meffert S; Gallinat S; Unger T
Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor.
Brain research. Molecular brain research 1998;53(1-2):187-95.
1998: Maier T; Dai W J; Csikós T; Jirikowski G F; Unger T; Culman J
Oxytocin pathways mediate the cardiovascular and behavioral responses to substance P in the rat brain.
Hypertension 1998;31(1 Pt 2):480-6.
1998: Gohlke P; Pees C; Unger T
AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
Hypertension 1998;31(1 Pt 2):349-55.
1998: Chung O; Unger T
Pharmacology of angiotensin receptors and AT1 receptor blockers.
Basic research in cardiology 1998;93 Suppl 2():15-23.
1998: Chung O; Unger T
Angiotensin II receptors in the kidney.
Kidney & blood pressure research 1998;21(2-4):245-8.
1997: Tschöpe C; Yu M; Reinecke A; Csikos T; Hilgenfeldt U; Pesquero J B; Ritz E; Unger T
Renal expression of two rat kallikrein genes under diabetic conditions.
Journal of hypertension 1997;15(12 Pt 2):1711-4.
1997: Willenbrock R; Stauss H; Scheuermann M; Osterziel K J; Unger T; Dietz R
Effect of chronic volume overload on baroreflex control of heart rate and sympathetic nerve activity.
The American journal of physiology 1997;273(6 Pt 2):H2580-5.
1997: Culman J; Ritter S; Ohlendorf C; Haass M; Maser-Gluth C; Spitznagel H; Unger T
A new formalin test allowing simultaneous evaluation of cardiovascular and nociceptive responses.
Canadian journal of physiology and pharmacology 1997;75(10-11):1203-11.
1997: Unger T
[New antihypertensive drugs: reasons for hope]
Fortschritte der Medizin 1997;115(26):58-9.
1997: Zhu Y C; Zhu Y Z; Gohlke P; Stauss H M; Unger T
Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.
The American journal of cardiology 1997;80(3A):110A-117A.
1997: Tschöpe C; Gohlke P; Zhu Y Z; Linz W; Schölkens B; Unger T
Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins.
Journal of cardiac failure 1997;3(2):133-48.
1997: Gallinat S; Csikos T; Meffert S; Herdegen T; Stoll M; Unger T
The angiotensin AT2 receptor down-regulates neurofilament M in PC12W cells.
Neuroscience letters 1997;227(1):29-32.
1997: Csikós T; Gallinat S; Unger T
Extrarenal aspects of angiotensin II function.
European journal of endocrinology / European Federation of Endocrine Societies 1997;136(4):349-58.
1997: Schmitt B M; Unger T; Rettig R
Circulating Na+/K+-ATPase inhibitors: effects of neuropeptides, volume expansion and salt loading in conscious rats.
Clinical and experimental pharmacology & physiology 1997;24(2):131-8.
1997: Blume A; Lebrun C J; Herdegen T; Bravo R; Linz W; Möllenhoff E; Unger T
Increased brain transcription factor expression by angiotensin in genetic hypertension.
Hypertension 1997;29(2):592-8.
1997: Gohlke P; Kuwer I; Schnell A; Amann K; Mall G; Unger T
Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.
Hypertension 1997;29(1 Pt 2):478-82.
1997: Culman J; Klee S; Ohlendorf C; Unger T
Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress.
The Journal of pharmacology and experimental therapeutics 1997;280(1):238-46.
1996: Unger T; Chung O; Csikos T; Culman J; Gallinat S; Gohlke P; Höhle S; Meffert S; Stoll M; Stroth U; Zhu Y Z
Angiotensin receptors.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1996;14(5):S95-103.
1996: Lebrun C J; Blume A; Herdegen T; Möllenhoff E; Unger T
Complex activation of inducible transcription factors in the brain of normotensive and spontaneously hypertensive rats following central angiotensin II administration.
Regulatory peptides 1996;66(1-2):19-23.
1996: Gohlke P; Linz W; Schölkens B A; Wiemer G; Unger T
Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats.
Hypertension 1996;28(3):397-402.
1996: Meffert S; Stoll M; Steckelings U M; Bottari S P; Unger T
The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells.
Molecular and cellular endocrinology 1996;122(1):59-67.
1996: Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
British journal of clinical practice. Supplement 1996;84():1-10.
1996: Tschöpe C; Gavriluk V; Reinecke A; Seidl U; Riester U; Hilgenfeldt U; Ritz E; Unger T
Bradykinin excretion is increased in severely hyperglycemic streptozotocin-diabetic rats.
Immunopharmacology 1996;33(1-3):344-8.
1996: Höhle S; Culman J; Boser M; Qadri F; Unger T
Effect of angiotensin AT2 and muscarinic receptor blockade on osmotically induced vasopressin release.
European journal of pharmacology 1996;300(1-2):119-23.
1996: Zhu Y C; Zhu Y Z; Spitznagel H; Gohlke P; Unger T
Substrate metabolism, hormone interaction, and angiotensin-converting enzyme inhibitors in left ventricular hypertrophy.
Diabetes 1996;45 Suppl 1():S59-65.
1996: Chung O; Stoll M; Unger T
Physiologic and pharmacologic implications of AT1 versus AT2 receptors.
Blood pressure. Supplement 1996;2():47-52.
1995: Stoll M; Meffert S; Stroth U; Unger T
Growth or antigrowth: angiotensin and the endothelium.
Journal of hypertension 1995;13(12 Pt 2):1529-34.
1995: Culman J; Itoi K; Unger T
Hypothalamic tachykinins. Mediators of stress responses?
Annals of the New York Academy of Sciences 1995;771():204-18.
1995: Höhle S; Blume A; Lebrun C; Culman J; Unger T
Angiotensin receptors in the brain.
Pharmacology & toxicology 1995;77(5):306-15.
1995: Gohlke P; Unger T
Chronic low-dose treatment with perindopril improves cardiac function in stroke-prone spontaneously hypertensive rats by potentiation of endogenous bradykinin.
The American journal of cardiology 1995;76(15):41E-45E.
1995: Edling O; Bao G; Feelisch M; Unger T; Gohlke P
Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
The Journal of pharmacology and experimental therapeutics 1995;275(2):854-63.
1995: Rohmeiss P; Beyer C; Nagy E; Tschöpe C; Höhle S; Strauch M; Unger T
NaCl injections in brain induce natriuresis and blood pressure responses sensitive to ANG II AT1 receptors.
The American journal of physiology 1995;269(2 Pt 2):F282-8.
1995: Lebrun C J; Möllenhoff E; Bao G; Culman J; Unger T
Angiotensin II induces the expression of c-fos mRNA in the central nervous system of the rat.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1995;17(6):877-93.
1995: Tschöpe C; Jost N; Unger T; Culman J
Central cardiovascular and behavioral effects of carboxy- and amino-terminal fragments of substance P in conscious rats.
Brain research 1995;690(1):15-24.
1995: Culman J; Unger T
Central tachykinins: mediators of defence reaction and stress reactions.
Canadian journal of physiology and pharmacology 1995;73(7):885-91.
1995: Zhu Y C; Stauss H M; Bao G; Gohlke P; Zhu Y Z; Redlich T; Unger T
Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitors.
Canadian journal of physiology and pharmacology 1995;73(7):827-31.
1995: Höhle S; Spitznagel H; Rascher W; Culman J; Unger T
Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist.
European journal of pharmacology 1995;275(3):277-82.
1995: Lebrun C J; Blume A; Herdegen T; Seifert K; Bravo R; Unger T
Angiotensin II induces a complex activation of transcription factors in the rat brain: expression of Fos, Jun and Krox proteins.
Neuroscience 1995;65(1):93-9.
1995: Culman J; Wiegand B; Spitznagel H; Klee S; Unger T
Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.
British journal of pharmacology 1995;114(6):1310-6.
1995: Stoll M; Steckelings U M; Paul M; Bottari S P; Metzger R; Unger T
The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
The Journal of clinical investigation 1995;95(2):651-7.
1995: Falkenhahn M; Franke F; Bohle R M; Zhu Y C; Stauss H M; Bachmann S; Danilov S; Unger T
Cellular distribution of angiotensin-converting enzyme after myocardial infarction.
Hypertension 1995;25(2):219-26.
1995: Culman J; Höhle S; Qadri F; Edling O; Blume A; Lebrun C; Unger T
Angiotensin as neuromodulator/neurotransmitter in central control of body fluid and electrolyte homeostasis.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1995;17(1-2):281-93.
1995: Unger T
Patient-doctor interactions in hypertension.
Journal of human hypertension 1995;9(1):41-5.
1994: Itoi K; Jost N; Culman J; Tschöpe C; Unger T
Further localization of cardiovascular and behavioral actions of substance P in the rat brain.
Brain research 1994;668(1-2):100-6.
1994: Stauss H M; Zhu Y C; Redlich T; Adamiak D; Mott A; Kregel K C; Unger T
Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
Journal of cardiovascular risk 1994;1(3):255-62.
1994: Gohlke P; Kuwer I; Bartenbach S; Schnell A; Unger T
Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin.
Journal of cardiovascular pharmacology 1994;24(3):462-9.
1994: Gohlke P; Linz W; Schölkens B A; Kuwer I; Bartenbach S; Schnell A; Unger T
Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.
Hypertension 1994;23(4):411-8.
1994: Gohlke P; Linz W; Schölkens B A; Wiemer G; Martorana P; Van Even P; Unger T
Effect of chronic high- and low-dose ACE inhibitor treatment on cardiac and vascular hypertrophy and vascular function in spontaneously hypertensive rats.
Experimental nephrology 1994;2(2):93.
1994: Qadri F; Edling O; Wolf A; Gohlke P; Culman J; Unger T
Release of angiotensin in the paraventricular nucleus in response to hyperosmotic stimulation in conscious rats: a microdialysis study.
Brain research 1994;637(1-2):45-9.
1994: Unger T; Gohlke P
Converting enzyme inhibitors in cardiovascular therapy: current status and future potential.
Cardiovascular research 1994;28(2):146-58.
1994: Itoi K; Jost N; Tschöpe C; Culman J; Badoer E; Unger T
Inhibition by morphine of the cardiovascular and behavioral responses evoked by centrally administered substance P in conscious rats.
Neuropharmacology 1994;33(2):181-7.
1994: Steckelings U M; Unger T
[Controlling blood pressure by centrally acting drugs--still a topic?]
Fortschritte der Medizin 1994;112(3):25-6.
1994: Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
Journal of cardiovascular pharmacology 1994;24 Suppl 2():S6-13.
1993: Unger T; Ganten D; Johnston C I; Lever A F; Mullins J J; Sassard J; van Zwieten P A
Round table 1. Do transgenic techniques help us to understand hypertension?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S374-9.
1993: Chung O; Schips T; Rohmeiss P; Gretz N; Strauch M; Unger T
Protein excretion and renal adaptation of transgenic mRen2 rats to changing oral sodium loads.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1993;11(5):S188-9.
1993: Lebrun C J; Wende P; Steckelings U; Itoi K; Unger T
Effects of tachykinins on phosphoinositide metabolism in the hypothalamus: is the NK1 receptor involved?
Brain research 1993;632(1-2):74-9.
1993: Qadri F; Culman J; Veltmar A; Maas K; Rascher W; Unger T
Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.
The Journal of pharmacology and experimental therapeutics 1993;267(2):567-74.
1993: Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Linz W; Schölkens B A; Wiemer G; Unger T
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
Hypertension 1993;22(5):682-7.
1993: Culman J; Tschöpe C; Jost N; Itoi K; Unger T
Substance P and neurokinin A induced desensitization to cardiovascular and behavioral effects: evidence for the involvement of different tachykinin receptors.
Brain research 1993;625(1):75-83.
1993: Culman J; Tschöpe C; Picard P; Prat A; Regoli D; Couture R; Unger T
In vivo characterization of tachykinin receptors responsible for the central cardiovascular effects of substance P and neurokinin A.
Regulatory peptides 1993;46(1-2):364-6.
1993: Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Unger T
Vascular remodeling in systemic hypertension.
The American journal of cardiology 1993;71(17):2E-7E.
1993: Behm R; Mewes H; DeMuinck Keizer W H; Unger T; Rettig R
Cardiovascular and renal effects of hypoxia in conscious carotid body-denervated rats.
Journal of applied physiology (Bethesda, Md. : 1985) 1993;74(6):2795-800.
1993: Behm R; Franz U; de Muinck Keizer W H; Mewes H; Rettig R; Unger T
Effects of chemoreceptor stimulation by almitrine bismesylate on renal function in conscious rats.
Advances in experimental medicine and biology 1993;337():315-21.
1992: Veltmar A; Culman J; Qadri F; Rascher W; Unger T
Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release.
The Journal of pharmacology and experimental therapeutics 1992;263(3):1253-60.
1992: Persson P B; Stauss H; Chung O; Wittmann U; Unger T
Spectrum analysis of sympathetic nerve activity and blood pressure in conscious rats.
The American journal of physiology 1992;263(5 Pt 2):H1348-55.
1992: Fletcher E C; Lesske J; Culman J; Miller C C; Unger T
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.
Hypertension 1992;20(5):612-9.
1992: Tschöpe C; Picard P; Culman J; Prat A; Itoi K; Regoli D; Unger T; Couture R
Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat.
British journal of pharmacology 1992;107(3):750-5.
1992: Unger T; Mattfeldt T; Lamberty V; Bock P; Mall G; Linz W; Schölkens B A; Gohlke P
Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries.
Hypertension 1992;20(4):478-82.
1992: Steckelings U M; Bottari S P; Unger T
Angiotensin receptor subtypes in the brain.
Trends in pharmacological sciences 1992;13(9):365-8.
1992: Itoi K; Tschöpe C; Jost N; Culman J; Lebrun C; Stauss B; Unger T
Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats.
European journal of pharmacology 1992;219(3):435-44.
1992: Gohlke P; Bünning P; Unger T
Distribution and metabolism of angiotensin I and II in the blood vessel wall.
Hypertension 1992;20(2):151-7.
1992: Gohlke P; Stoll M; Lamberty V; Mattfeld T; Mall G; van Even P; Martorana P; Unger T
Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(6):S141-4.
1992: Bao G; Gohlke P; Qadri F; Unger T
Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril.
Hypertension 1992;20(1):74-9.
1992: Fletcher E C; Lesske J; Qian W; Miller C C; Unger T
Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats.
Hypertension 1992;19(6 Pt 1):555-61.
1992: Steckelings U M; Obermüller N; Bottari S P; Qadri F; Veltmar A; Unger T
Brain angiotensin: receptors, actions and possible role in hypertension.
Pharmacology & toxicology 1992;70(6 Pt 2):S23-7.
1992: Fletcher E C; Lesske J; Behm R; Miller C C; Stauss H; Unger T
Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea.
Journal of applied physiology (Bethesda, Md. : 1985) 1992;72(5):1978-84.
1992: Stadler T; Veltmar A; Qadri F; Unger T
Angiotensin II evokes noradrenaline release from the paraventricular nucleus in conscious rats.
Brain research 1992;569(1):117-22.
1992: Gohlke P; Bünning P; Bönner G; Unger T
ACE inhibitor effect on bradykinin metabolism in the vascular wall.
Agents and actions. Supplements 1992;38 ( Pt 3)():178-85.
1992: Steckelings U; Lebrun C; Qadri F; Veltmar A; Unger T
Role of brain angiotensin in cardiovascular regulation.
Journal of cardiovascular pharmacology 1992;19 Suppl 6():S72-9.
1992: Bao G; Gohlke P; Unger T
Kinin contribution to chronic antihypertensive actions of ACE-inhibitors in hypertensive rats.
Agents and actions. Supplements 1992;38 ( Pt 2)():423-30.
1992: Bao G; Gohlke P; Unger T
Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models.
Journal of cardiovascular pharmacology 1992;20 Suppl 9():S96-9.
1991: Rettig R; Folberth C G; Graf C; Kopf D; Stauss H; Unger T
Post-transplantation hypertension in recipients of renal grafts from hypertensive donor rats.
Clinical and investigative medicine. Médecine clinique et experimentale 1991;14(6):492-8.
1991: Veltmar A; Qadri F; Culman J; Rascher W; Unger T
Catecholaminergic pathway involved in angiotensin II-induced vasopressin release.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S56-7.
1991: Qadri F; Badoer E; Stadler T; Unger T
Angiotensin II-induced noradrenaline release from anterior hypothalamus in conscious rats: a brain microdialysis study.
Brain research 1991;563(1-2):137-41.
1991: Obermüller N; Unger T; Culman J; Gohlke P; de Gasparo M; Bottari S P
Distribution of angiotensin II receptor subtypes in rat brain nuclei.
Neuroscience letters 1991;132(1):11-5.
1991: Rettig R; Folberth C G; Graf C; Kopf D; Stauss H; Unger T
Are renal mechanisms involved in primary hypertension? Evidence from kidney transplantation studies in rats.
Klinische Wochenschrift 1991;69(13):597-602.
1991: Rohmeiss P; Demmert G; Unger T
Central effects of atrial natriuretic factor on renal salt excretion.
The American journal of physiology 1991;261(2 Pt 2):F354-9.
1991: Itoi K; Jost N; Badoer E; Tschöpe C; Culman J; Unger T
Localization of the substance P-induced cardiovascular responses in the rat hypothalamus.
Brain research 1991;558(1):123-6.
1991: Rettig R; Unger T
The role of the kidney in the aetiology of hypertension: renal transplantation studies in rats.
Trends in pharmacological sciences 1991;12(7):243-5.
1991: Bao G; Qadri F; Stauss B; Stauss H; Gohlke P; Unger T
HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats.
European journal of pharmacology 1991;200(1):179-82.
1991: Veltmar A; Gohlke P; Unger T
From tissue angiotensin converting enzyme inhibition to antihypertensive effect.
American journal of hypertension 1991;4(3 Pt 2):263S-269S.
1991: Unger T; Gohlke P; Paul M; Rettig R
Tissue renin-angiotensin systems: fact or fiction?
Journal of cardiovascular pharmacology 1991;18 Suppl 2():S20-5.
1990: Danckwardt L; Shimizu I; Bönner G; Rettig R; Unger T
Converting enzyme inhibition in kinin-deficient brown Norway rats.
Hypertension 1990;16(4):429-35.
1990: Lebrun C J; Gruber M G; Meister M; Unger T
Central vasopressin pretreatment sensitizes phosphoinositol hydrolysis in the rat septum.
Brain research 1990;531(1-2):167-72.
1990: Unger T; Gohlke P
Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
The American journal of cardiology 1990;65(19):3I-10I.
1990: Rettig R; Folberth C G; Stauss H; Kopf D; Waldherr R; Baldauf G; Unger T
Hypertension in rats induced by renal grafts from renovascular hypertensive donors.
Hypertension 1990;15(4):429-35.
1990: Rettig R; Folberth C; Stauss H; Kopf D; Waldherr R; Unger T
Role of the kidney in primary hypertension: a renal transplantation study in rats.
The American journal of physiology 1990;258(3 Pt 2):F606-11.
1990: Rohmeiss P; Photiadis J; Rohmeiss S; Unger T
Hemodynamic actions of intravenous endothelin in rats: comparison with sodium nitroprusside and methoxamine.
The American journal of physiology 1990;258(2 Pt 2):H337-46.
1990: Rettig R; Folberth C; Kopf D; Stauss H; Unger T
Role of the kidney in the pathogenesis of primary hypertension.
Clinical and experimental hypertension. Part A, Theory and practice 1990;12(6):957-1002.
1990: Unger T; Badoer E; Gareis C; Girchev R; Kotrba M; Qadri F; Rettig R; Rohmeiss P
Atrial natriuretic peptide (ANP) as a neuropeptide: interaction with angiotensin II on volume control and renal sodium handling.
British journal of clinical pharmacology 1990;30 Suppl 1():83S-88S.
1989: Lebrun C J; Rohmeiss P; Demmert G; Unger T
Sensitization to pressor effects by repeated central injections of vasopressin in conscious rats.
Brain research 1989;505(1):39-43.
1989: Unger T; Gohlke P; Kotrba M; Rettig R; Rohmeiss P
Angiotensin II and atrial natriuretic peptide in the brain: effects on volume and Na+ balance.
Resuscitation 1989;18(2-3):309-19.
1989: Rohmeiss P; Demmert G; Rettig R; Unger T
Centrally administered atrial natriuretic factor inhibits central angiotensin-induced natriuresis.
Brain research 1989;502(1):198-203.
1989: Luft F C; Wilcox C S; Unger T; Kühn R; Demmert G; Rohmeiss P; Ganten D; Sterzel R B
Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins.
Hypertension 1989;14(4):396-403.
1989: Rettig R; Geist R; Sauer U; Rohmeiss P; Unger T
Central effects of somatostatin: pressor response, AVP release, and sympathoinhibition.
The American journal of physiology 1989;257(3 Pt 2):R588-94.
1989: Veelken R; Danckwart L; Rohmeiss P; Unger T
Effects of intravenous AVP on cardiac output, mesenteric hemodynamics, and splanchnic nerve activity.
The American journal of physiology 1989;257(2 Pt 2):H658-64.
1989: Rettig R; Stauss H; Folberth C; Ganten D; Waldherr B; Unger T
Hypertension transmitted by kidneys from stroke-prone spontaneously hypertensive rats.
The American journal of physiology 1989;257(2 Pt 2):F197-203.
1989: Badoer E; Würth H; Türck D; Qadri F; Itoi K; Dominiak P; Unger T
Selective local action of angiotensin II on dopaminergic neurons in the rat hypothalamus in vivo.
Naunyn-Schmiedeberg's archives of pharmacology 1989;340(1):31-5.
1989: Unger T; Horst P J; Bauer M; Demmert G; Rettig R; Rohmeiss P
Natriuretic action of central angiotensin II in conscious rats.
Brain research 1989;486(1):33-8.
1989: Gohlke P; Urbach H; Schölkens B; Unger T
Inhibition of converting enzyme in the cerebrospinal fluid of rats after oral treatment with converting enzyme inhibitors.
The Journal of pharmacology and experimental therapeutics 1989;249(2):609-16.
1989: Badoer E; Würth H; Türck D; Qadri F; Itoi K; Dominiak P; Unger T
The K+-induced increases in noradrenaline and dopamine release are accompanied by reductions in the release of their intraneuronal metabolites from the rat anterior hypothalamus. An in vivo brain microdialysis study.
Naunyn-Schmiedeberg's archives of pharmacology 1989;339(1-2):54-9.
1989: Gohlke P; Schölkens B; Henning R; Urbach H; Unger T
Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288.
Journal of cardiovascular pharmacology 1989;14 Suppl 4():S32-6.
1989: Unger T; Gohlke P; Ganten D; Lang R E
Converting enzyme inhibitors and their effects on the renin-angiotensin system of the blood vessel wall.
Journal of cardiovascular pharmacology 1989;13 Suppl 3():S8-16.
1988: Horst P J; Bauer M; Veelken R; Unger T
A new method for collecting urine directly from the ureter in conscious unrestrained rats.
Renal physiology and biochemistry 1988;11(6):325-31.
1988: Veelken R; Schelling P; Unger T
An approach to measuring cardiac output with Doppler flow probes in conscious rats.
The American journal of physiology 1988;255(5 Pt 2):H1206-10.
1988: Mann J F; Eisele S; Rettig R; Unger T; Johnson A K; Ganten D; Ritz E
Renin-dependent water intake in hypovolemia.
Pflügers Archiv : European journal of physiology 1988;412(6):574-8.
1988: Unger T; Carolus S; Demmert G; Ganten D; Lang R E; Maser-Gluth C; Steinberg H; Veelken R
Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization.
Circulation research 1988;63(4):812-20.
1988: Badoer E; Würth H; Qadri F; Itoi K; Unger T
Central noradrenergic pathways are not involved in the pressor response to intracerebroventricular substance P.
European journal of pharmacology 1988;154(1):105-8.
1988: Hermann K; Ganten D; Unger T; Bayer C; Lang R E
Measurement and characterization of angiotensin peptides in plasma.
Clinical chemistry 1988;34(6):1046-51.
1988: Unger T; Badoer E; Ganten D; Lang R E; Rettig R
Brain angiotensin: pathways and pharmacology.
Circulation 1988;77(6 Pt 2):I40-54.
1988: Jin M; Wilhelm M J; Lang R E; Unger T; Lindpaintner K; Ganten D
Endogenous tissue renin-angiotensin systems. From molecular biology to therapy.
The American journal of medicine 1988;84(3A):28-36.
1988: Steinberg H; Medvedev O S; Luft F C; Unger T
Effect of a prostacyclin derivative (iloprost) on regional blood flow, sympathetic nerve activity, and baroreceptor reflex in the conscious rat.
Journal of cardiovascular pharmacology 1988;11(1):84-9.
1987: Lebrun C; Rohmeiss P; Demmert G; Rettig R; Unger T
Central cardiovascular actions of vasopressin in the rat.
Canadian journal of physiology and pharmacology 1987;65(8):1712-6.
1987: Lindpaintner K; Wilhelm M J; Jin M; Unger T; Lang R E; Schoelkens B A; Ganten D
Tissue renin-angiotensin systems: focus on the heart.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1987;5(2):S33-8.
1987: Moursi M; el-Dakhakhny M; Schölkens B A; Unger T
Interference with the autonomic nervous system by the converting enzyme inhibitor ramipril in conscious spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1987;10 Suppl 7():S125-8.
1987: Unger T; Demmert G; Rohmeiss P; Veelken R; Luft F C
Dissociation between heart rate and sympathetic nerve responses to baroreceptor activation in spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1987;10 Suppl 12():S221-4.
1986: Luft F C; Demmert G; Rohmeiss P; Unger T
Baroreceptor reflex effect on sympathetic nerve activity in stroke-prone spontaneously hypertensive rats.
Journal of the autonomic nervous system 1986;17(3):199-209.
1986: Unger T; Rohmeiss P; Demmert G; Ganten D; Lang R E; Luft F C
Differential modulation of the baroreceptor reflex by brain and plasma vasopressin.
Hypertension 1986;8(6 Pt 2):II157-62.
1986: Unger T; Rohmeiss P; Demmert G; Luft F C; Ganten D; Lang R E
Differential actions of neuronal and hormonal vasopressin on blood pressure and baroreceptor reflex sensitivity in rats.
Journal of cardiovascular pharmacology 1986;8 Suppl 7():S81-6.
1984: Hermann K; Lang R E; Unger T; Bayer C; Ganten D
Combined high-performance liquid chromatography-radioimmunoassay for the characterization and quantitative measurement of neuropeptides.
Journal of chromatography 1984;312():273-84.
1983: Ganten D; Hermann K; Bayer C; Unger T; Lang R E
Angiotensin synthesis in the brain and increased turnover in hypertensive rats.
Science (New York, N.Y.) 1983;221(4613):869-71.

Sign-in to see more